Company Search:
Advanced Search
Sponsored Links
Carna Biosciences Inc Company Snapshot
Carna Biosciences Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Carna Biosciences Inc with three other companies in this sector in Japan: Human Metabolome Technologies Inc (2016 sales of 780.38 million Japanese Yen [US$6.95 million] of which 90% was Metabolome analysis business), Raqualia Pharma Incorporated (705.24 million Japanese Yen [US$6.28 million] of which 100% was Pharmaceutical), and BrightPath Biotherapeutics Co Ltd (822.56 million Japanese Yen [US$7.33 million] of which 100% was Commerical Physical Research).

Sales Analysis. During the year ended December of 2016, sales at Carna Biosciences Inc were ¥811.60 million (US$7.23 million). This is a sharp decrease of 48.3% versus 2015, when the company's sales were ¥1.57 billion. Contributing to the drop in overall sales was the 83.9% decline in Drug Discovery Business, from ¥614.85 million to ¥98.93 million. There were also decreases in sales in Drug Discovery Support Business (down 25.3% to ¥712.67 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Carna Biosciences Inc
  Stock Performance Chart for Carna Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 1,183.00
(Figures in Japanese Yen)
1 Week -1.3%   13 Weeks -3.4%  
4 Weeks -2.7%   52 Weeks -35.7%  
Carna Biosciences Inc Key Data:
  Ticker: 4572 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 811,598,000
(Year Ending Jan 2017).
Employees: 60
  Currency: Japanese Yen Market Cap: 11,289,671,848
  Fiscal Yr Ends: December Shares Outstanding: 9,543,256
  Share Type: Common Closely Held Shares: 1,598,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.